2024 STI Clinical Update: San Francisco Department of Public Health (SFDPH)
Thursday, March 14, 2024
Hybrid event. Please note: CME not available for viewing the recording.
Presented by:
Dr. Oliver Bacon
Medical Director, San Francisco City Clinic
San Francisco Department of Public Health
Dr. Franco Chevalier
Deputy Medical Director, San Francisco City Clinic
San Francisco Department of Public Health
Dr. Stephanie Cohen
Director, HIV/STI Prevention, Disease Control Branch,
San Francisco Department of Public Health
Dr. Kelly Johnson
Medical Director, California Prevention Training Center
Public Health Medical Officer, STD Control Branch, California Department of Public Health
Emcee: Dr. Ina Park
Principal Investigator, California Prevention Training Center
Description
More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2022, and San Francisco has higher chlamydia, gonorrhea, syphilis, and HIV rates compared to the rest of the state and nation. This half-day, hybrid event will provide important updates in the field of sexual health to help providers strengthen the delivery of STI prevention and care. Hear from local experts on STI epidemiology in San Francisco, updates on Doxy-PEP implementation, recognizing dermatologic manifestations of STIs, and a lively case panel.
Learning Objectives
- Summarize current STI trends in San Francisco
- Be familiar with updates to STI treatment guidelines and innovations in STI prevention and diagnostics
- Understand how to implement Doxy-PEP for STI prevention
- Recognize common dermatologic manifestations of STIs